Inborn errors of metabolism elicit unique challenges for therapy development
In recent years, major progress has been made in the development of gene therapies for rare diseases. However, research for…
Analysis
Magazine: Radiopharmaceutical deals drive sector growth despite supply crisis
GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
EU reshapes HTAs: is the industry ready for it?
Treating alcohol addiction: filling the medication gap
Radiopharmaceutical deals drive sector growth despite supply crisis
The AI advantage in discovering new medicines
Pharmaceutical Technology Excellence Awards 2024 – Winners Announced!
